Preliminary Relationship Between Serum Cystatin C Level and Parkinson's Disease

Jinmin Xu,Jing Chen,Chengjie Mao,Yaping Yang,Chunfeng Liu
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2014.11.002
2014-01-01
Abstract:Objective To explore the role of serum cystatin C level in Parkinson's disease (PD) and evaluate the relationship between cystatin C level and clinical characteristics and different stages of PD.Methods A total of 115 PD patients and 110 healthy controls were recruited.The results of such routine laboratory tests as triglyceride,cholesterol,low-density lipoprotein (LDL),high-density lipoprotein (HDL),creatinine,urea,uric acid and cystatin C were assessed from fasting blood samples at our clinical laboratory center.They were further divided into subgroups according to Hoehn & Yahr (H&Y) staging.Statistical analysis was performed with SPSS version 17.0 software.Results Compared to controls (0.96 ± 0.16 mg/L),the mean serum level of cystatin C was significantly higher in PD patients (1.06 ± 0.20 mg/L).Spearman's correlation analyses showed a positive and significant correlation between cystatin C levels and age as well as creatinine levels.Correlation was not found between cystatin C level and triglyceride,cholesterol,LDL,HDL,urea or uric acid.ANOVA analysis showed that cystatin C had a higher level during the middle and late stages of PD than that during the early stage.Conclusion Cystatin C level may play an important role in the progression of PD.
What problem does this paper attempt to address?